PharmaShots Weekly Snapshots (May 10 - 14, 2021)
Published: May 14, 2021 | Tags: AzurRx BioPharma, P-II, MS1819, PERT, Cystic Fibrosis, Severe, Exocrine Pancreatic Insufficiency
Published: May 14, 2021 | Tags: Goldfinch Bio, P-I, Clinical Trial, GFB-024, Severe Insulin Resistant Diabetic Nephropathy
Published: May 14, 2021 | Tags: Reistone, P-III, RSJ10333 Trial, SHR0302, Atopic Dermatitis
Published: May 14, 2021 | Tags: Heron Therapeutics, Zynrelef, HTX-011, US, FDA, Approval, Postoperative Pain
Novo Nordisk Reports Results of Semaglutide from P-IIIa STEP 1 Trial in Patients with Obesity
Published: May 14, 2021 | Tags: Novo Nordisk, Semaglutide, P-IIIa, STEP 1 Trial, Obesity
Published: May 14, 2021 | Tags: Biogen, Envisagenics, RNA Splicing Research, AI Technology, Central Nervous System Diseases
Dr Reddy's Acquires an Exclusive License for Pregene's PRG1801 in India
Published: May 13, 2021 | Tags: Dr. Reddy's, Exclusive License, Pregene, PRG1801, India
Published: May 13, 2021 | Tags: Fulcrum Therapeutics, US FDA, Fast Track Designation, Losmapimod, Facioscapulohumeral Muscular Dystrophy
Published: May 13, 2021 | Tags: AstraZeneca, Amgen, Tezepelumab, P-III, NAVIGATOR Study, Severe Asthma, ATS2021
Published: May 13, 2021 | Tags: Antengene, IND, Approval, P- III, SIENDO Trial, Selinexor, Advanced, Recurrent Endometrial Cancer
Biogen Exercises its Option to Acquire TMS-007 for Acute Ischemic Stroke
Published: May 13, 2021 | Tags: Biogen, TMS, TMS-007, Acute Ischemic Stroke, Acquisition
Published: May 13, 2021 | Tags: Regeneron, Sanofi, Libtayo, cemiplimab, P-III, Trial, Cervical Cancer, ESMO2021
Published: May 12, 2021 | Tags: InflaRx, Vilobelimab, P- II, IXPLORE Study, Anti-Neutrophil Cytoplasmic Auto-Antibody, Vasculitis
Published: May 12, 2021 | Tags: Medtronic, SonarMed Airway Monitoring System, Airway Obstruction, Ventilation, Pediatric Patients
Published: May 12, 2021 | Tags: Nanobiotix, Lianbio, NBTXR3, Head & Neck Squamous Cell Carcinoma, China, Korea, Singapore, Thailand
Published: May 12, 2021 | Tags: Incyte, MorphoSys, P-III, frontMIND Study, Tafasitamab, Lenalidomide, DLBCL
Cellectis Collaborates with Sanofi for Alemtuzumab to be Utilized in CART-Cell Trials
Published: May 12, 2021 | Tags: Cellectis, Sanofi, Alemtuzumab, CART-Cell Trials
Published: May 12, 2021 | Tags: Autobahn, Global Rights, Astellas, ASP3652, Brain Targeting Chemistry Platform
Lilly Signs a ~$1.25B Research Collaboration with MiNA Therapeutics to Develop saRNA Therapies
Published: May 11, 2021 | Tags: Lilly, ~$1.25B, MiNA Therapeutics, saRNA Therapies
Published: May 11, 2021 | Tags: Biogen, Capsigen, Novel AAV Capsids, CNS, Neuromuscular Disorders
Allergan Aesthetics to Acquire Soliton and its Resonic Device for ~$550M
Published: May 11, 2021 | Tags: Allergan Aesthetics, Soliton, Resonic Device, ~$550M
AstraZeneca and Amgen Submit BLA to US FDA for Tezepelumab to Treat Severe Asthma
Published: May 11, 2021 | Tags: AstraZeneca, Amgen, BLA, US, FDA, Tezepelumab, Severe Asthma
Pfizer and BioNTech Receive the US FDA's EMA for COVID-19 Vaccine in Adolescents
Published: May 11, 2021 | Tags: Pfizer, BioNTech, US, FDA, EMA, COVID-19 Vaccine, Adolescents
Published: May 11, 2021 | Tags: Bayer, Finerenone, P- III, FIGARO-DKD CV Outcomes Study, Chronic Kidney Disease, Type 2 Diabetes
Published: May 10, 2021 | Tags: Aurinia, Lupkynis, voclosporin, P-III, AURORA 1 Study, Active Lupus Nephritis, The Lancet
Published: May 10, 2021 | Tags: Pfizer, BioNTech, BLA, US, FDA, Approval, COVID-19 Vaccine
Walmart Health Signs an Agreement to Acquire MeMD for its Telehealth Services
Published: May 10, 2021 | Tags: Walmart Health, MeMD, Telehealth Services
Published: May 10, 2021 | Tags: Eli Lilly, Diabetes Technology Companies, Connected, Insulin Pen Solutions
BD to Spin Off its Diabetes Care Business into New Public Company
Published: May 10, 2021 | Tags: BD, Spin Off, Diabetes Care Business, New Public Company
Published: May 10, 2021 | Tags: GSK, Vir, EMA, VIR-7831, sotrovimab, COVID-19
Related Post: PharmaShots Weekly Snapshots (May 03 - 07, 2021)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com